scholarly journals Safety and efficacy of modified schedula of anti-EGFR monoclonal antibodies plus chemotherapy as first line treatment in metastatic colorectal cancer patients

2015 ◽  
Vol 26 ◽  
pp. vi52
Author(s):  
S. Mancarella ◽  
O. Poti ◽  
D. De Giorgi ◽  
M.L. Schirinzi ◽  
G. De Maria ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Monoclonal Antibodies ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Safety And Efficacy ◽  
Colorectal Cancer Patients ◽  
First Line Treatment

scholarly journals IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 16887-16898 ◽  
Author(s):  
Mariantonietta Di Salvatore ◽  
Filippo Pietrantonio ◽  
Armando Orlandi ◽  
Marzia Del Re ◽  
Rosa Berenato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Enos Polymorphisms ◽  
First Line Treatment

The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis

2018 ◽  
Vol 125 ◽  
pp. 69-77 ◽  
Author(s):  
Domenico Ciliberto ◽  
Nicoletta Staropoli ◽  
Francesca Caglioti ◽  
Silvia Chiellino ◽  
Antonella Ierardi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Meta Analysis ◽  
Line Treatment ◽  
Wild Type ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document